Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation.
暂无分享,去创建一个
[1] W. Lowther,et al. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. , 2005, Biochemistry.
[2] C. Smith,et al. Isolation and characterization of two mouse Pi-class glutathione S-transferase genes. , 1994, The Biochemical journal.
[3] F. Ali-Osman,et al. Genetic polymorphism at the glutathione S‐tranferase (GST) P1 locus is a breast cancer risk modifier , 2001, International journal of cancer.
[4] G. B. Smith,et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.
[5] M. Anderson,et al. Dynamic state of glutathione in blood plasma. , 1980, The Journal of biological chemistry.
[6] A. Holmgren,et al. Catalysis of Thiol/Disulfide Exchange , 2005, Journal of Biological Chemistry.
[7] Simon C Watkins,et al. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. , 1997, Journal of medicinal chemistry.
[8] Jie Liu,et al. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. , 2004, Molecular Cancer Therapeutics.
[9] D. Townsend,et al. A novel role for human sulfiredoxin in the reversal of glutathionylation. , 2006, Cancer research.
[10] W. Nelson,et al. Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated π-Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells* , 2002, The Journal of Biological Chemistry.
[11] J. Mieyal,et al. Glutathione-Thiyl Radical Scavenging and Transferase Properties of Human Glutaredoxin (Thioltransferase) , 2003, The Journal of Biological Chemistry.
[12] C. Wolf,et al. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Ghibelli,et al. Proapoptotic activity of new glutathione S-transferase inhibitors. , 2005, Cancer research.
[14] B. Ketterer,et al. Ligandin: a Hepatic Protein which Binds Steroids, Bilirubin, Carcinogens and a Number of Exogenous Organic Anions , 1971, Nature.
[15] A. English,et al. Protein S-glutathiolation triggered by decomposed S-nitrosoglutathione. , 2004, Biochemistry.
[16] A. Naing,et al. Developmental therapeutics for myelodysplastic syndromes. , 2006, The Journal of the National Comprehensive Cancer Network.
[17] C. Grant,et al. The yeast Saccharomyces cerevisiae contains two glutaredoxin genes that are required for protection against reactive oxygen species. , 1998, Molecular biology of the cell.
[18] J. Keck,et al. Phase 1 Study of TLK286 (Telcyta) Administered Weekly in Advanced Malignancies , 2004, Clinical Cancer Research.
[19] P. van Bladeren,et al. Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1. , 1994, Cancer research.
[20] A. Sorribas,et al. Grx5 Glutaredoxin Plays a Central Role in Protection against Protein Oxidative Damage inSaccharomyces cerevisiae , 1999, Molecular and Cellular Biology.
[21] K. Schulze-Osthoff,et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] R. Ozols,et al. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. , 1991, Cancer Research.
[23] M. Pincus,et al. Regulation of JNK signaling by GSTp , 1999, The EMBO journal.
[24] K. M. Davies,et al. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. , 2003, Molecular cancer therapeutics.
[25] W. Pearson,et al. Nomenclature for human glutathione transferases. , 1992, The Biochemical journal.
[26] K. M. Davies,et al. PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. , 2006, Journal of medicinal chemistry.
[27] G. Filomeni,et al. Glutathione disulfide induces apoptosis in U937 cells by a redox‐mediated p38 mitogen‐activated protein kinase pathway , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] J. Rudolph,et al. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. , 2003, Biochemistry.
[29] K. Tew,et al. Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. , 2000, Cancer research.
[30] S. Kohno,et al. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. , 1999, Free radical research.
[31] K. Tew,et al. Cellular response to a glutathione S-transferase P1-1 activated prodrug. , 2000, Molecular pharmacology.
[32] L. Kauvar,et al. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines , 1996, Cancer Chemotherapy and Pharmacology.
[33] K. Tew,et al. Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. , 1991, Biochemical pharmacology.
[34] K. Tew,et al. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. , 1988, Cancer research.
[35] J. Brooks,et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Ghezzi,et al. Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Piantadosi,et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. , 2001, Cancer research.
[38] A. Caccuri,et al. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate , 2005, Amino Acids.
[39] L. Keefer. Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. , 2005, Current topics in medicinal chemistry.
[40] P. Vineis,et al. Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] D. Townsend,et al. A Glutathione S-Transferase π-Activated Prodrug Causes Kinase Activation Concurrent with S-Glutathionylation of Proteins , 2006, Molecular Pharmacology.
[42] A. Fisher,et al. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. , 2006, Biochemistry.
[43] E. Burova,et al. Transactivation of the Epidermal Growth Factor Receptor by Oxidized Glutathione and Its Pharmacological Analogue Glutoxim® in A431 Cells , 2005, Doklady Biological Sciences.
[44] B. Bennett,et al. Regulation of microsomal and cytosolic glutathione S-transferase activities by S-nitrosylation. , 2002, Biochemical pharmacology.
[45] Wang Al,et al. Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. , 1985 .
[46] K. Tew,et al. Increased Myeloproliferation in Glutathione S-Transferase π-deficient Mice Is Associated with a Deregulation of JNK and Janus Kinase/STAT Pathways* , 2004, Journal of Biological Chemistry.
[47] F. G. Hopkins. On an Autoxidisable Constituent of the Cell. , 1921, The Biochemical journal.
[48] Kuo-ping Huang,et al. Glutathionylation of proteins by glutathione disulfide S-oxide. , 2002, Biochemical pharmacology.
[49] K. Houk,et al. On the acidity and reactivity of HNO in aqueous solution and biological systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Feelisch,et al. Oxidation and Nitrosation of Thiols at Low Micromolar Exposure to Nitric Oxide , 2003, The Journal of Biological Chemistry.
[51] L. Kauvar,et al. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. , 1998, Cancer research.
[52] M. Spiteri,et al. Simultaneous identification of GSTP1 Ile105→Val105 and Ala114→Val114 substitutions using an amplification refractory mutation systempolymerase chain reactionassay: studies in patients with asthma , 2001, Respiratory research.
[53] K. Tew,et al. Cellular thiols and reactive oxygen species in drug-induced apoptosis. , 2001, The Journal of pharmacology and experimental therapeutics.
[54] J. Landry,et al. Activation of the p38 Signaling Pathway by Heat Shock Involves the Dissociation of Glutathione S-Transferase Mu from Ask1* , 2002, The Journal of Biological Chemistry.
[55] D. Wink,et al. Discriminating formation of HNO from other reactive nitrogen oxide species. , 2006, Free radical biology & medicine.
[56] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[57] A. Tulpule,et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. , 1986, The Journal of biological chemistry.
[58] M. Lyttle,et al. Glutathione-S-transferase activates novel alkylating agents. , 1994, Journal of medicinal chemistry.
[59] D. Forman,et al. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. , 1997, Carcinogenesis.
[60] K. Tew,et al. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. , 2001, The Journal of pharmacology and experimental therapeutics.
[61] E. Wagner,et al. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis , 2002, Oncogene.
[62] S. Rockwell,et al. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] F. Ali-Osman,et al. Structure of the human allelic glutathione S-transferase-pi gene variant, hGSTP1 C, cloned from a glioblastoma multiforme cell line. , 1998, Chemico-biological interactions.
[64] A. Meister,et al. Glutathione turnover in the kidney; considerations relating to the gamma-glutamyl cycle and the transport of amino acids. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Strange,et al. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. , 1999, IARC scientific publications.
[66] K. Patel,et al. Multi‐institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S‐transferase P1‐1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer , 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[67] G. Filomeni,et al. Cell signalling and the glutathione redox system. , 2002, Biochemical pharmacology.
[68] D. Townsend,et al. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. , 2004, Molecular pharmacology.
[69] K. Kang,et al. Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1* , 2001, The Journal of Biological Chemistry.
[70] K. Tew,et al. Glutathione S-transferase P1–1 (GSTP1–1) Inhibits c-Jun N-terminal Kinase (JNK1) Signaling through Interaction with the C Terminus* , 2001, The Journal of Biological Chemistry.
[71] G. Kirby,et al. Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. , 2006, The Biochemical journal.
[72] J. Johnson,et al. Tissue distribution of enzymic methylation of glutathione S-transferase and its effects on catalytic activity. Methylation of glutathione S-transferase 11-11 inhibits conjugating activity towards 1-chloro-2,4-dinitrobenzene. , 1992, The Biochemical journal.
[73] Kohei Miyazono,et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.
[74] A. Holmgren,et al. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. , 2004, Antioxidants & redox signaling.
[75] S. Groshen,et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. , 2002, Journal of the National Cancer Institute.
[76] K. Tew,et al. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. , 1999, The Journal of pharmacology and experimental therapeutics.
[77] P. B. Chock,et al. Regulation of PTP1B via glutathionylation of the active site cysteine 215. , 1999, Biochemistry.
[78] G. Bellí,et al. Biochemical Characterization of Yeast Mitochondrial Grx5 Monothiol Glutaredoxin* , 2003, Journal of Biological Chemistry.
[79] D. Wink,et al. Nitroxyl (HNO): chemistry, biochemistry, and pharmacology. , 2005, Annual review of pharmacology and toxicology.
[80] M. Chamberlain,et al. Increased Constitutive c-Jun N-terminal Kinase Signaling in Mice Lacking Glutathione S-Transferase Pi* , 2003, Journal of Biological Chemistry.
[81] C. Wolf,et al. Disruption of the glutathione transferase pi class genes. , 2005, Methods in enzymology.
[82] Clement Ip,et al. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. , 2006, Cancer research.
[83] Giovanni Antonini,et al. 7-Nitro-2,1,3-benzoxadiazole Derivatives, a New Class of Suicide Inhibitors for Glutathione S-Transferases , 2005, Journal of Biological Chemistry.
[84] K. Tew,et al. Evidence for a glycoconjugate form of glutathione S-transferase pI. , 2009, International journal of peptide and protein research.
[85] A. Fisher,et al. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. , 2005, Free radical biology & medicine.
[86] B. Ketterer,et al. The structure of the human glutathione S-transferase pi gene. , 1988, The Biochemical journal.
[87] Y. Jiang,et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signals , 2006, Oncogene.
[88] D. Townsend,et al. The role of glutathione-S-transferase in anti-cancer drug resistance , 2003, Oncogene.